Latest Articles

31. 03. 2020

List of reimbursed medicinal products valid as of 1.4.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

09. 03. 2020

Q&A from workshop 11.11.2019

Questions and answers from workshop on 11.11.2019

 

28. 02. 2020

List of reimbursed medicinal products valid as of 1.3.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

31. 01. 2020

List of reimbursed medicinal products valid as of 1.2.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

31. 12. 2019

List of reimbursed medicinal products valid as of 1.1.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

29. 11. 2019

List of reimbursed medicinal products valid as of 1.12.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

29. 11. 2019

Requirement for Marketing Authorisation Holders to Evaluate the Risk of the Presence of Nitrosamines

In compliance with the procedure outlined under Art. 5(3) of Regulation (EC) no. 726/2004, holders of marketing authorisations of human medicinal products containing...

 

06. 11. 2019

Correction of the List of reimbursed medicinal products valid as of 6.11.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...